Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines.
Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines.
复制标题
血小板激活因子诱导的人血小板聚集被三唑并苯二氮卓类药物特异性抑制。
DOI:
10.1126/science.6150550
复制
发表时间:
1984
期刊:
影响因子:
--
通讯作者:
Lenox,RH
中科院分区:
文献类型:
--
作者:
Kornecki,E;Ehrlich,YH;Lenox,RH
Platelet-activating factor (PAF), a naturally occurring phospholipid, is a potent activator of various biological processes, including platelet aggregation. The mechanisms by which PAF acts are largely unknown, partly because of the lack of specific inhibitors for PAF-elicited responses. It was found that in washed human platelets the psychotropic triazolobenzodiazepine drugs alprazolam and triazolam potently inhibited PAF-induced changes in shape, aggregation, and secretion. The effects were specific for PAF activation, since the responses of human platelets to adenosine diphosphate, thrombin, epinephrine, collagen, arachidonate, and the calcium ionophore A23187 were not inhibited by the triazolobenzodiazepines. These psychotropic drugs should be useful in investigating the possibility that PAF or PAF-like phospholipids play a role in neuronal function and in elucidating biochemical mechanisms activated specifically by PAF in a variety of cells.